160 Health International Narrows Loss in 2025

MT Newswires Live

03/27

160 Health International (HKG:2656) narrowed its attributable loss to 73 million yuan in 2025 from 107.7 million yuan a year prior, according to a Friday Hong Kong bourse filing.

The Chinese pharmaceutical and healthcare product wholesaler's loss per share stood at 0.24 yuan, compared with 0.37 yuan in the previous fiscal year.

Revenue was 651.9 million yuan in the year, up 5% from 620.7 million yuan in the prior-year period.

The higher revenue was driven by a positive performance of the company's digital healthcare and wellness solutions and sale of pharmaceutical and healthcare products.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hant/news/2622082193"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2622082193\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2622082193?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-27 20:44","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2622082193","market":"us","top_or_hot":-1,"title":"160 Health International Narrows Loss in 2025","media":"MT Newswires Live","content":"<html><body><p> 160 Health International (HKG:2656) narrowed its attributable loss to 73 million yuan in 2025 from 107.7 million yuan a year prior, according to a Friday Hong Kong bourse filing.</p><p>The Chinese pharmaceutical and healthcare product wholesaler's loss per share stood at 0.24 yuan, compared with 0.37 yuan in the previous fiscal year.</p><p>Revenue was 651.9 million yuan in the year, up 5% from 620.7 million yuan in the prior-year period.</p><p>The higher revenue was driven by a positive performance of the company's digital healthcare and wellness solutions and sale of pharmaceutical and healthcare products.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>160 Health International Narrows Loss in 2025</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n160 Health International Narrows Loss in 2025\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time smaller\">2026-03-27 20:44</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<html><body><p> 160 Health International (HKG:2656) narrowed its attributable loss to 73 million yuan in 2025 from 107.7 million yuan a year prior, according to a Friday Hong Kong bourse filing.</p><p>The Chinese pharmaceutical and healthcare product wholesaler's loss per share stood at 0.24 yuan, compared with 0.37 yuan in the previous fiscal year.</p><p>Revenue was 651.9 million yuan in the year, up 5% from 620.7 million yuan in the prior-year period.</p><p>The higher revenue was driven by a positive performance of the company's digital healthcare and wellness solutions and sale of pharmaceutical and healthcare products.</p></body></html>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4588","symbol_name":"碎股","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2622082193","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2622082193","pubTimestamp":1774615481,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"160 Health International  narrowed its attributable loss to 73 million yuan in 2025 from 107.7 million yuan a year prior, according to a Friday Hong Kong bourse filing.The Chinese pharmaceutical and healthcare product wholesaler's loss per share stood at 0.24 yuan, compared with 0.37 yuan in the previous fiscal year.Revenue was 651.9 million yuan in the year, up 5% from 620.7 million yuan in the prior-year period.The higher revenue was driven by a positive performance of the company's digital healthcare and wellness solutions and sale of pharmaceutical and healthcare products.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4588":"碎股","BK4585":"ETF&股票定投概念","BK4550":"红杉资本持仓","IXJ":"全球医疗业ETF-iShares","VHT":"Vanguard Health Care ETF","02656":"健康160","BK1197":"保健护理产品经销商"},"translate_title":"160 Health International 2025年亏损收窄","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02656":1,"VHT":0.68,"IXJ":0.68},"content_text":"160 Health International (HKG:2656) narrowed its attributable loss to 73 million yuan in 2025 from 107.7 million yuan a year prior, according to a Friday Hong Kong bourse filing.The Chinese pharmaceutical and healthcare product wholesaler's loss per share stood at 0.24 yuan, compared with 0.37 yuan in the previous fiscal year.Revenue was 651.9 million yuan in the year, up 5% from 620.7 million yuan in the prior-year period.The higher revenue was driven by a positive performance of the company's digital healthcare and wellness solutions and sale of pharmaceutical and healthcare products.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}